Another Classic Textbook Case
Good Evening All Longs, Newbies & Olde.
Quite the ride, good & bad, and it is what it is. Looking at Stockwatch, with 7 trading platforms involved with KNR trading today, I see $ 20.3M total $ traded with 3.5185M shares involved. Thus providing an avg sp trade of $ 5.77 per share.
So don't let the Close of $ 4.98 mislead you vs the avg sp value traded here today. The $ 6.64 - 52 week high as of today is simply a sign of greater things to come, IMO.
The reasons how/why I started buying into KNR a month ago were for the same reasons I had bought into PYR several years ago.
My investment strategy then & now ( adj. recently too because of Covid) was to review a firm for what it had to offer an investor & the final consumers. As follows:
1) Proven/successful Disruptive or Highly Disruptive tech adressing strong/very strong market demand.
2) Patents/patent pending
3) Proven solid management track record progress as reflected in:
a) Blue Chip Partnerships
b) Blue Chip Clients
c) Blue Sky Opportunities
d) Several Lucrative Biz Verticals
4) Large Management share holdings of the firm itself
5) Very capable/timely informative Communications with Shareholders, Clients, Consumers & the General Public
6) Minimal free floating shares
7) Real Potential listing on Major Trading Exchanges
8) the firm's biz is an Essential service
Take the time & review the past 6 months of news/interviews/ progress/sp moves of PYR because it is a classic textbook case of what is to come with KNR.
Like KNR, IMO, the contracts will be coming in, which will truly be Transformative for the firms as they go Blue Chip.
Looking at what has transpired re: the Bullboard postings as PYR being an eg. to compare, we Will see a Very large poster increase with KNR eg. soft/hard Bashers, Shorters, Professional Players/Manipulators with the intent of misleading Longs in general.to give up their KNR shares.
Bottom line is, do your DD before and after any investment you may make. And Decide what course of action to take that works best with your investment strategy.
Risk/Reward. Always something to weigh upon reviewing a firm's potentials.
To sum things up for myself, I remain Long in both firms in which I believe strongly that Both will enrich All Patient Longs well into the future.
Best wishes to All, good health,
Sincerely,
Topseeker
P.S. Because the BioCloud is tied so intimately in the fight with the Covid outbreak, the News tends to go Ballistic( Globally) upon further success/progress of the unit. Certainly very very good for All shareholders. Topseeker
1